Table 1 Characteristics of patients
Parameters | The LAC group n = 13 | The HAC group n = 7 | |
|---|---|---|---|
General | |||
Gender (male), n(%) | 5 (38.46%) | 6 (85.71%) | |
Median Age (year), (range) | 1.67 (0.33–4.58) | 2.67 (1.42–9.83) | |
DAS after initial therapy | 2 (0–5) | 2 (0–7) | |
Duration before diagnosis (W) | 44.71 (6.14−120.43) | 20.14 (8−156.43) | |
Follow-up time (years) | 4.10 (0.92–6.67) | 5.21 (2.68–6.23) | |
Organ involvement and Laboratory tests | |||
Liver involvement | 11 (84.61%) | 6 (85.761%) | |
Spleen involvement | 7 (53.85%) | 3 (42.86%) | |
Hematology dysfunction | 3 (23.08%) | 0 (0%) | |
AST (U/L) | 34.3 (11.3-131.6) | 53.8 (17.9–98.8) | |
ALT (U/L) | 16.9 (9.2-226.3) | 30.6 (10.1–82.5) | |
γ-GGT (U/L) | 24 (12.2−182.1) | 33.7 (9.1−479.7) | |